Table 4 Mid-term prognosis and follow-up results of the two groups.
Before PSM (n = 119) | After PSM (n = 50) | |||||||
|---|---|---|---|---|---|---|---|---|
TAR with FET (n = 88) | HAR (n = 31) | t/χ2 | P value | TAR with FET (n = 25) | HAR (n = 25) | t/χ2 | P value | |
Aortic diameter of true lumen | ||||||||
Ascending aorta (mm) | 26.3 ± 0.9 | 26.4 ± 1.0 | -0.333 | 0.739 | 26.2 ± 0.9 | 26.3 ± 0.9 | 0.012 | 1.000 |
Aortic arch (mm) | 27.1 ± 1.1 | 29.3 ± 1.5 | -8.227 | < 0.001 | 26.8 ± 1.2 | 29.1 ± 1.9 | -5.117 | < 0.001 |
Middle descending thoracic aorta (mm) | 21.4 ± 1.9 | 23.7 ± 2.1 | -5.374 | < 0.001 | 21.6 ± 1.8 | 24.1 ± 1.9 | -4.776 | < 0.001 |
Renal artery level (mm) | 19.2 ± 2.5 | 19.9 ± 2.7 | -1.252 | 0.213 | 19.0 ± 2.3 | 19.9 ± 2.6 | -1.296 | 0.201 |
Middle abdominal aorta level (mm) | 18.1 ± 2.4 | 19.0 ± 2.5 | -1.695 | 0.093 | 17.8 ± 2.3 | 19.1 ± 2.4 | -1.955 | 0.056 |
False lumen thrombosis# | ||||||||
Distal arch level (n, %) | 71 (94.7) | 28 (96.6) | 0.162 | 0.687 | 23 (92.0) | 25 (100.0) | 1.000* | |
Middle descending thoracic aorta (n, %) | 47 (62.7) | 24 (82.8) | 3.897 | 0.048 | 15 (60.0) | 21 (84.0) | 3.571 | 0.059 |
Renal artery level (n, %) | 14 (18.7) | 11 (37.9) | 4.250 | 0.039 | 4 (16.0) | 10 (40.0) | 3.571 | 0.059 |
Middle abdominal aorta level (n, %) | 9 (12.0) | 6 (20.7) | 1.279 | 0.258 | 2 (8.0) | 5 (20.0) | 1.495 | 0.221 |
Internal leakage (n, %) | 6 (8.0) | 2 (6.9) | 0.036 | 0.850 | 2 (8.0) | 1 (4.0) | 1.000* | |
Follow-up mortality (n, %) | 7 (9.3) | 2 (6.9) | 0.157 | 0.692 | 2 (8.0) | 1 (4.0) | 1.000* | |
Reoperation (n, %) | 6 (8.0) | 1 (3.4) | 0.690 | 0.406 | 2 (8.0) | 1 (4.0) | 1.000* | |